1,202
Views
90
CrossRef citations to date
0
Altmetric
Research Article

The manufacturing techniques of drug-loaded polymeric nanoparticles from preformed polymers

&
Pages 323-335 | Received 08 Nov 2010, Accepted 28 Feb 2011, Published online: 17 May 2011

References

  • Ahlin P, Kristl J, Kristl A, Vrecer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int J Pharm 2002; 239: 113–20
  • Ahlin P, Kristl J, Pecar S, Strancar J, Sentjurc M. The effect of lipophilicity of spin-labeled compounds on their distribution in solid lipid nanoparticle dispersions studied by electron paramagnetic resonance. J Pharm Sci 2003; 92: 58–66
  • Ahlin P, Kristl J, Sentjurc M, Strancar J, Pecar S. Influence of spin probe structure on its distribution in SLN dispersions. Int J Pharm 2000a; 196: 241–4
  • Ahlin P, Sentjurc M, Strancar J, Kristl J. Location of lipophilic substances and ageing of solid lipid nanoparticles studied by EPR. STP Pharma Sci 2000b; 10: 125–32
  • Ahmed El-Harati A, Charcosset C, Fessi H. Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor. Pharm Dev Technol 2006; 11: 153–7
  • Allémann E, Gurny R, Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: Influence of process parameters on particle size. Int J Pharm 1992; 87: 247–53
  • Allemann E, Gurny R, Doelker E. Drug-loaded nanoparticles: Preparation methods and drug targeting issues. Eur J Pharm Biopharm 1993; 39: 173–91
  • Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007; 59: 478–90
  • Alonso MJ. Nanoparticulate drug carrier technology. Microparticulate systems for the delivery of proteins and vaccines, S Cohen, H Bernstein. Marcel Dekker, New York 1996; 203–42
  • Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates – A review. J Control Release 2008; 128: 185–99
  • Bala I, Hariharan S, Kumar M. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21: 387–422
  • Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 2005a; 24: 67–75
  • Bilati U, Allémann E, Doelker E. Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech 2005b; 6: 594–604
  • Bindschaedler C, Gurny R, Doelker E. Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereof. Swiss Patent 1497/88, 1988
  • Byrappa K, Ohara S, Adschiri T. Nanoparticles synthesis using supercritical fluid technology – towards biomedical applications. Adv Drug Deliv Rev 2008; 60: 299–327
  • Cai C, Bakowsky U, Rytting E, Schaper AK, Kissel T. Charged nanoparticles as protein delivery systems: A feasibility study using lysozyme as model protein. Eur J Pharm Biopharm 2008; 69: 31–42
  • Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997; 63: 125–32
  • Cegnar M, Kos J, Kristl J. Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: Development and fundamental studies on preservation of its activity. Eur J Pharm Sci 2004; 22: 357–64
  • Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 2005; 108: 112–20
  • Charcosset C, Fessi H. A new process for drug loaded nanocapsules preparation using a membrane contactor. Drug Dev Ind Pharm 2005a; 31: 987–92
  • Charcosset C, Fessi H. Preparation of nanoparticles with a membrane contactor. J Membr Sci 2005b; 266: 115–20
  • Charcosset C, Fessi H. A membrane contactor for the preparation of nanoparticles. Desalination 2006; 200: 568–9
  • Ciach T. Microencapsulation of drugs by electro-hydro-dynamic atomization. Int J Pharm 2006; 324: 51–5
  • Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release 2009; 133: 90–5
  • Crotts G, Gwan Park T. Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles. J Control Release 1997; 44: 123–34
  • Crotts G, Park TG. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues. J Microencapsul 1998; 15: 699–713
  • Dalwadi G, Benson HAE, Chen Y. Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions. Pharm Res 2005; 22: 2152–62
  • des Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release 2006; 116: 1–27
  • Ding L, Lee T, Wang CH. Fabrication of monodispersed Taxol-loaded particles using electrohydrodynamic atomization. J Control Release 2005; 102: 395–413
  • Eerikainen H, Kauppinen EI. Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method. Int J Pharm 2003; 263: 69–83
  • Eerikäinen H, Kauppinen EI, Kansikas J. Polymeric drug nanoparticles prepared by an aerosol flow reactor method. Pharm Res 2004; 21: 136–43
  • Eerikäinen H, Watanabe W, Kauppinen EI, Ahonen PP. Aerosol flow reactor method for synthesis of drug nanoparticles. Eur J Pharm Biopharm 2003; 55: 357–60
  • Egle R, Milek M, Mlinaric-Rascan I, Fahr A, Kristl J. A novel gene delivery system for stable transfection of thiopurine-S-methyltransferase gene in versatile cell types. Eur J Pharm Biopharm 2008; 69: 23–30
  • Fernandez JC, Tiera MJ, Winnik FM. DNA-chitosan nanoparticles for gene therapy: Current knowledge and future trends. Biological and pharmaceutical nanomaterials, CSSR Kumar. Wiley-VCH, Weinheim 2006; 68–115
  • Fessi H, Devissaguet JP, Puisieux F. Procédé de préparation de systèmes colloïdaux dispersibles d’une substance sous forme de nanocapsules. French Patent 8618444, 1986
  • Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm 1989; 55: R1–4
  • Frokjaer S, Otzen DE. Protein drug stability: A formulation challenge. Nat Rev Drug Discov 2005; 4: 298–306
  • Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res 2004; 21: 1428–39
  • Galindo-Rodriguez SA, Puel F, Briancon S, Allemann E, Doelker E, Fessi H. Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur J Pharm Sci 2005; 25: 357–67
  • Gasper MM, Blanco D, Cruz ME, Alonso MJ. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: Influence of polymer properties on enzyme loading, activity and in vitro release. J Control Release 1998; 52: 53–62
  • Ginty PJ, Whitaker MJ, Shakesheff KM, Howdle SM. Drug delivery goes supercritical. Mater Today 2005; 8: 42–8
  • Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release 1999; 57: 171–85
  • Gurny R, Peppas NA, Harrington DD, Banker GS. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Dev Ind Pharm 1981; 7: 1–25
  • Heinzen C, Pluess-Wenzinger R, Widmer F, Brandenberger H. Method and device for capsulating microbal, plant and animal cells or biological and chemical substances. US Patent 6458296, 2000
  • Ibrahim H, Bindschaedler C, Doelker E, Buri P, Gurny R. Aqueous nanodispersions prepared by a salting-out process. Int J Pharm 1992; 87: 239–46
  • Irache JM, Bergougnoux L, Ezpeleta I, Gueguen J, Orecchioni AM. Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method. Int J Pharm 1995; 126: 103–9
  • Irache JM, Espuelas S. Albumin nanoparticles. Biological and pharmaceutical nanomaterials, CSSR Kumar. Wiley-VCH, Weinheim 2006; 185–218
  • Jaiswal J, Kumar Gupta S, Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J Control Release 2004; 96: 169–78
  • Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ. Chitosan nanoparticles as delivery systems for doxorubicin. J Controlled Release, 2001;73:255–67
  • Jaworek A. Micro- and nanoparticle production by electrospraying. Powder Technol 2007; 176: 18–35
  • Jaworek A. Electrostatic micro- and nanoencapsulation and electroemulsification: A brief review. J Microencapsul 2008; 25: 443–8
  • Jaworek A, Sobczyk AT. Electrospraying route to nanotechnology: An overview. J Electrostat 2008; 66: 197–219
  • Jayagopal A, Shastri P. Nanoengineering of drug delivery systems. Nanoparticulate drug delivery systems, D Thassu, M Deleers, Y Pathak. Informa Healthcare, New York 2007; 99–111
  • Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives. Pharm Res 1998; 15: 1103–10
  • Johnson OL. Formulation of proteins for incorporation into drug delivery systems. Protein formulation and delivery, EJ McNally. Marcel Dekker, New York 2000; 235–56
  • Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 2007; 120: 18–26
  • Kramer P. Albumin microspheres as vehicles for achieving specificity in drug delivery. J Pharm Sci 1974; 63: 1646–7
  • Kristl J, Ahlin Grabnar P, Cegnar M, Vrečer F, Kos J. Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously. WO/2003/099262, 2003
  • Kristl J, Alleman E, Gurny R. Formulation and evaluation of zinc phthalocyanine loaded poly(D,L-lactic acid) nanoparticles. Acta Pharm 1996; 46: 1–12
  • Kristl J, Smidkorbar J, Struc E, Schara M, Rupprecht H. Hydrocolloids and gels of chitosan as drug carriers. Int J Pharm 1993; 99: 13–19
  • Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf A Physicochem Eng 2001; 182: 123–30
  • Langer K. Peptide nanoparticles. In: , Kumar CSSR, ed. Biological and pharmaceutical nanomaterials. Wiley-VCH, Weinheim 2006; 145–84
  • Lee LY, Wang CH, Smith KA. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel. J Control Release 2008; 125: 96–106
  • Leo E, Vandelli MA, Cameroni R, Forni F. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: Involvement of the drug in the cross-linking process. Int J Pharm 1997; 155: 75–82
  • Leroux JC, Allemann E, Doelker E, Gurny R. New approach for the preparation of nanoparticles by an emulsification-diffusion method. Eur J Pharm Biopharm 1995; 41: 14–8
  • Marty J, Oppenheim R, Speiser P. Nanoparticles – a new colloidal drug delivery system. Pharm Acta Helv 1978; 53: 17–23
  • Merodio M, Arnedo A, Renedo MJ, Irache JM. Ganciclovir-loaded albumin nanoparticles: Characterization and in vitro release properties. Eur J Pharm Sci 2001; 12: 251–9
  • Meziani MJ, Pathak P, Desai T, Sun YP. Supercritical fluid processing of nanoscale particles from biodegradable and biocompatible polymers. Ind Eng Chem Res 2006; 45: 3420–4
  • Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010; 385: 113–42
  • Morimoto Y, Sugibayashi K, Kato Y. Drug-carrier property of albumin microspheres in chemotherapy. V. Antitumor effect of microsphere-entrapped adriamycin on liver metastasis of AH 7974 cells in rats. Chem Pharm Bull 1981; 29: 1433–8
  • Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): Protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 1997; 43: 29–36
  • Nakagawa Y, Takayama K, Ueda H, Machida Y, Nagai T. Preparation of bovine serum albumin nanospheres as drug targeting carriers. Drug Des \Deliv 1987; 2: 99–107
  • Peppas NA, Hilt JZ, Thomas JB. Nanotechnology in therapeutics: Current technology and applications. Horizon Bioscience, Wymondham 2007
  • Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998; 24: 1113–28
  • Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. Development of a new drug carrier made from alginate. J Pharm Sci 1993; 82: 912–17
  • Raula J, Eerikäinen H, Kauppinen EI. Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles. Int J Pharm 2004; 284: 13–21
  • Raula J, Eerikainen H, Lahde A, Kauppinen EI. Aerosol flow reactor method for the synthesis of multicomponent drug nano- and microparticles. Nanoparticulate drug delivery systems, D Thassu, M Deleers, Y Pathak. Informa Healthcare, New York 2007; 111–29
  • Sane A, Limtrakul J. Formation of retinyl palmitate-loaded poly(L-lactide) nanoparticles using rapid expansion of supercritical solutions into liquid solvents (RESOLV). J Supercrit Fluids 2009; 51: 230–7
  • Scheffel U, Rhodes BA, Natarajan TK, Wagner HN. Albumin microspheres for study of the reticuloendothelial system. J Nucl Med 1972; 13: 498–503
  • Sun YP, Meziani MJ, Pathak P, Qu L. Polymeric nanoparticles from rapid expansion of supercritical fluid solution. Chemistry 2005; 11: 1366–73
  • van de Weert M, Hoechstetter J, Hennink WE, Crommelin DJA. The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release 2000; 68: 351–9
  • Vauthier-Holtzscherer C, Benabbou S, Spenlehauer G, Veillard M, Couvreur P. Methodology for the preparation of ultra-dispersed polymer systems. STP Pharma Sci 1991; 2: 109–16
  • Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res, 2009;26:1025–58
  • Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 2005; 289: 1–30
  • Wei Q, Wei W, Lai B, Wang LY, Wang YX, Su ZG, Ma GH. Uniform-sized PLA nanoparticles: Preparation by premix membrane emulsification. Int J Pharm 2008; 359: 294–7
  • Xie J, Lim LK, Phua Y, Hua J, Wang CH. Electrohydrodynamic atomization for biodegradable polymeric particle production. J Colloid Interface Sci 2006; 302: 103–12
  • Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release 1998; 50: 31–40
  • Zvonar A, Kristl J, Kerc J, Ahlin Grabnar P. High celecoxib-loaded nanoparticles prepared by a vibrating nozzle device. J Microencapsul 2009; 26: 748–59

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.